Various medical devices require connection to a patient's heart, and more particularly, require a connection that provides fluid communication with a chamber of the heart. For example, the class of cardiovascular medical products referred to as “mechanical circulatory support” (MCS), including blood pump systems such as Left Ventricular Assist Devices (LVAD), require a fluid connection to a heart chamber. An LVAD is a medical device for patients in heart failure to bridge these patients to cardiac transplantation (“bridge-to-transplant”) or for longer-term, permanent use (“destination therapy”). An LVAD works by draining blood from the patient's poorly-functioning left ventricle and pumping the blood to the aorta. A blood inflow cannula functions as a conduit to drain the blood from the heart to the LVAD or other pumping device so that the blood may be pumped to the aorta.
In accordance with certain aspects of the disclosure, a cannula system for a heart includes a cannula having an end configured for connection to a myocardium of a heart. In some examples, the opposite end of the cannula is configured for connection to an inlet of a pump, such as a LVAD pump. In some disclosed examples, the cannula defines an inlet and has a flange or other connector extending around the cannula. A first cuff extends around the cannula and covers a substantial portion of an exterior surface of the cannula between the flange and the inlet. For example, the first cuff may cover at least half or a majority of the exterior surface of the cannula between the flange and the inlet. By so constructing the first end of the cannula, the inlet extends into the patient's heart chamber minimally or not at all. For instance, in some embodiments, the tip extends not more than 5 mm beyond the endocardium, and in other examples the tip extends not more than 0.5 mm beyond the endocardium into the heart chamber. Additionally, a second cuff may be included that extends around the first end of the cannula adjacent the second end of the cannula at a distal end of the first cuff.
In the following Detailed Description, reference is made to the accompanying drawings, which form a part hereof, and in which is shown by way of illustration specific embodiments in which the invention may be practiced. In this regard, directional terminology, such as top, bottom, front, back, etc., is used with reference to the orientation of the Figure(s) being described. Because components of embodiments can be positioned in a number of different orientations, the directional terminology is used for purposes of illustration and is in no way limiting. It is to be understood that other embodiments may be utilized and structural or logical changes may be made without departing from the scope of the present invention. The following detailed description, therefore, is not to be taken in a limiting sense.
Various types of medical devices require connection to a human heart. Procedures such as aortic valve bypass and various heart pump installations require a fluid connection to a chamber of a human heart. For example, a ventricular assist device (VAD) is an electromechanical device that partially or completely replaces the function of a failing heart. Some VADs are for short-term use, while others are for long-term use. VADs are designed to assist either the right ventricle (RVAD) or the left ventricle (LVAD), or to assist both ventricles (BiVAD). The type of ventricular assistance device applied depends upon many factors.
The LVAD is the most common device applied to an impaired left heart function, but the right heart function can be impaired as well. In such situations, an RVAD might be necessary to resolve the problem of cardiac circulation. Normally, the long-term VAD is used as a bridge to transplantation—keeping alive the patient, with a good quality of life—while awaiting a heart transplant. In other circumstances, an LVAD may be applied as a bridge to recovery, and in still other circumstances, the LVAD may be applied as a long-term or permanent solution, also known as Destination Therapy (DT).
In the case of an LVAD, blood is drained from the left ventricle and pumped to the aorta. An inflow cannula is used to connect the heart to the fluid input of the LVAD. The cannula is inserted through the myocardial wall and engaged from the outside of the heart by surgical sutures. In general, known LVAD inflow cannulae clinically include a tip structure long enough to penetrate the myocardial wall and protrude well into the ventricular chamber to ensure that the cannula ostium is patent for blood drainage. However, a narrow space between the cannula tip extending into the ventricular chamber and the myocardial wall can cause an abnormal blood flow pattern around the cannula resulting in undesirable effects such as blood stagnation, turbulent flow, high shear flow, and flow separation, which may lead to blood clot-generation.
Also, the blood-contacting surface of the protruding cannula tip may be a source of blood clots and other vulnerable cell/fibrin deposition as a physiologic response to enhanced coagulation cascade. Blood clots tend to form around the cannula, such as “wedge thrombus”—thrombus developed at the gap between myocardium and cannula wall. If such blood clots are sucked into the LVAD, it could lead to strokes. Furthermore, cannula tip malposition in the left ventricle due to poor anatomical fitting of the LVAD-pump and cannula can enhance the blood clot issue. Moreover, the tilting cannula tip could also rub and abrade the septum if there is misalignment of the protruding tip. The tilting tip could also become occluded if impinging on the septum.
Attempts to mitigate problems outlined above have been largely insufficient. For instance, different shapes of cannula tips have been applied in an attempt to optimize blood flow patterns in the left ventricle, but there is no satisfactory solution to normalize the blood flow pattern in the left ventricle. Some known LVADs include a textured surface added to the smooth metal surface of the cannula. Titanium sintered beads are sometimes used as surface texturization for LVAD cannula, made out of pure titanium or titanium alloy. Titanium sintered beads permit or enhance the formation of a thin layer of blood clot and eventually neo-intimal tissue ingrowth can take place. Such cannula covered with neo-intimal tissue—or in other words, an endothelialized cannula surface—can demonstrate superior antithrombogenicity. However, according to the recent clinical reports, even if the inflow cannula is properly texturized, blood clot (or over pannus formation) have formed resulting in ischemic stroke (also called cerebrovascular accident or CVA).
Example devices disclosed herein operate to avoid or minimize blood stagnation, and inflow cannula malposition around the inflow cannulation site of heart. The ultimate goal is to mitigate the risk of cerebrovascular accidents such as ischemic stroke which can result from these problems. More particularly, various disclosed embodiments function to address possible root causes associated with current LVAD inflow cannula.
In some disclosed examples, protrusion of the cannula tip into the ventricle chamber is minimized or eliminated. Since there is no blood flow obstruction in the left ventricle, blood flow is more of a physiological pattern, and is particularly beneficial for avoiding blood stagnation around the ventricular apex. Since the cannula shows little or no wedge between the cannula wall and myocardium, theoretically there is no chance of wedge thrombus formation. Also, blood contacting surface area in the left ventricle is minimal.
Since the cannula does not extend significantly into the ventricle, there is no tilting tip against the ventricular wall, eliminating or at least reducing the chance of malposition. Disclosed arrangements where the cannula tip does not protrude into the ventricle are also avoid inflow ostium occlusion even after a failing heart is remodeled and the heart size shrinks.
The pump 10 is made of titanium, for example, and is powered through a percutaneous cable which transverses the patient's skin and connects to an external battery powered, controller in some embodiments. The blood outlet 24 is connected to the aorta 18 by an outflow graft, which is flexible and made of a sealed polyester material or e-PTFE (polytetrafluoroethylene) in some examples.
The illustrated cannula system 100 includes a cannula 110 with a first, or connection end 112 that is connected to the myocardium 120 of the heart 14, such that the cannula 110 is in fluid communication with the desired chamber 16 of the heart 14. An opposite end 114 of the cannula 110 connects, for example, to the inlet 20 of the pump 10. When implemented in conjunction with an LVAD, the connection end 112 of the cannula 110 is connected to the apex of the left ventricle of the heart 14. More particularly, the connection end 112 extends through the myocardium 120 such that an inlet 118 of the cannula 110 is in fluid communication with the left ventricle 16 of the heart 14. As shown in
A first, or proximal sewing cuff 130 extends around the connection end 112 of the cannula 110, and in the example shown in
As will be discussed further below, the apex of the ventricle 16 may be cored to allow the connection end 112 to be inserted into the apex of the ventricle 16. The connection end 112 is secured with an array of sutures 140 around the connection end 112 of the cannula 110. The sutures 140 are inserted through pledgets 134, which are small patches of fabric, usually PTFE or PET, which keep the sutures 140 from cutting the heart muscle. The sutures 140 go through the full thickness of the myocardium 120 and through the endocardium 122 and epicardium 124. The sutures 140 also extend through the proximal and distal sewing cuffs 130, 132, and are tied over the pledgets 134.
In some embodiments, the connection end 112 extends no more than 5 mm beyond the endocardium 122 into the heart chamber 14, and in some examples the connection end 112 extends no more than 0.5 mm beyond the endocardium 122 into the heart chamber 14. The proximal sewing cuff 130 is constructed of sufficient thickness and strength such that a suture 140 can traverse a portion of the interior of the first cuff In the illustrated example, the proximal sewing cuff is configured such that the sutures 140 are able to extend in a generally axial direction (up and down as shown in
The sutures 140 going through the endocardium 122 and the proximal sewing cuff 130 result in the myocardium 120 and endocardium 122 being pulled tight against the proximal sewing cuff 130. This protects the blood circulating in the left ventricle 16 from being exposed to the healing myocardium 120, thus reducing the risks of blood clots forming and being pulled into the pump 10. This also provides a seal to prevent or at least reduce blood from leaking along the connection end 112, which would need to be stopped by the distal sewing cuff 132.
The sutures 140 extending through the endocardium 122 and the proximal sewing cuff 130 provide hemostasis at the interior of the left ventricle 16, and a uniform extension of the cannula inlet 118 into the left ventricle 16. With the endocardium 122 fixed relative to the proximal sewing cuff 130, the flexible distal sewing cuff 132 has the effect of pulling the myocardium 120 such that it slightly reshapes the apex of the left ventricle 16 to more of a “U” shape versus a “V” shape. With known pump connections using only a single sewing cuff or other apparatus to secure the cannula tip to the left ventricle apex, when sutures are tightened on the distal cuff, the endocardium can “open up,” exacerbating the exposure of the cut myocardium to the left ventricle blood and increasing the likelihood for emboli causing a stroke. With the endocardium 122 fixed relative to the proximal sewing cuff 130, the distal cuff 132 would be flexible to accommodate a thick myocardium 120. The distal cuff 132 could also be movable along the tip 110 to accommodate a thick myocardium 120 while keeping the proximal sewing cuff 130 flush with the endocardium 120.
As mentioned above, the connection end 112 extends into the heart chamber 16 ideally as little as possible, between 0.5 and 5 mm in some examples. However, aspects of the disclosed cannula system 100 generally provides a uniform tip extension and could be applied to longer cannula tips extend farther into the heart chamber 16, for example, 10 to 20 mm.
As also noted previously, the disclosed cannula system 100 is not limited to use associated with the left or right ventricle. In addition to ventricular blood drainage, the cannula system 100 can be applied to right or left atrium drainage. For instance, a left atrial cannulation would be beneficial for diastolic heart failure and acute heart failure caused by myocardial infarction, which develop friable ventricular apex thus not applicable for apical cannulation.
Since there is little or no part of the cannula system 100 that protrudes into the interior of the heart chamber, a hemostatic plug can be safely inserted into the cannula 110 in situations where the patient's heart recovers and the pump 10 is explanted (“cardiac recovery case”).
In the example shown in
The illustrated cannula 110 further has a groove 138 extending around the cannula 110 adjacent the inlet 118. In one example, the cylindrical body of the cannula 110 has an inner diameter of 16.00 mm and an outer diameter of 19.5 mm, the flange 136 has a diameter of 27.00 mm, and the groove 138 has a diameter of 18.00 mm. Further, in the illustrated example, the cannula 110 is 30.00 mm high from top to bottom. The connection end 112 has a first height h1 of 10.00 mm as measured from the outer edge of the shoulder 136a to the inlet 118, and a second height h2 of 7.33 mm as measured from the junction of the top of the shoulder 136a and the exterior surface of the cannula 110 to the inlet 118. The groove 138 is 2.00 mm high and extends into the outer surface of the cannula 0.75 mm.
In the example shown in
The depth (up-and-down dimension as illustrated in
As shown in
The connection end 112 is parachuted down, with the proximal sewing cuff 130 situated inside the cored myocardium 120, and with the distal sewing cuff 132 resting outside the myocardium 120 against the epicardium 124. The mattress sutures 140 are tied off, and a continuous running suture is provided around distal sewing cuff 132 as shown in
Various modifications and alterations of this disclosure may become apparent to those skilled in the art without departing from the scope and spirit of this disclosure, and it should be understood that the scope of this disclosure is not to be unduly limited to the illustrative examples set forth herein.
This Application is being filed on Mar. 8, 2017, as a PCT International application claiming the benefit of U.S. Provisional Patent Application No. 62/396,606, filed on Sep. 19, 2016, the entire contents of which is incorporated by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2017/021358 | 3/8/2017 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62396606 | Sep 2016 | US |